G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 113 filers reported holding G1 THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.83 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $819,550 | -80.0% | 150,930 | -54.1% | 0.01% | -77.3% |
| Q3 2022 | $4,107,000 | +1087.0% | 328,800 | +871.1% | 0.02% | +1000.0% |
| Q4 2021 | $346,000 | -89.3% | 33,859 | -86.0% | 0.00% | -90.5% |
| Q3 2021 | $3,247,000 | -57.4% | 241,953 | -30.3% | 0.02% | -60.4% |
| Q2 2021 | $7,616,000 | -7.8% | 347,124 | +1.1% | 0.05% | -11.7% |
| Q1 2021 | $8,261,000 | +77.5% | 343,366 | +32.7% | 0.06% | +53.8% |
| Q4 2020 | $4,655,000 | +1978.1% | 258,777 | +1237.1% | 0.04% | +1850.0% |
| Q3 2020 | $224,000 | +7.2% | 19,354 | +2.2% | 0.00% | -66.7% |
| Q1 2020 | $209,000 | -50.4% | 18,943 | -25.3% | 0.01% | -53.8% |
| Q1 2019 | $421,000 | – | 25,366 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 98,482 | $1,631,000 | 0.60% |
| Opus Point Partners Management, LLC | 20,844 | $346,000 | 0.47% |
| HHLR ADVISORS, LTD. | 949,431 | $15,761,000 | 0.44% |
| Rhenman & Partners Asset Management AB | 212,169 | $3,522,000 | 0.41% |
| Virtus ETF Advisers LLC | 8,654 | $144,000 | 0.31% |
| BB BIOTECH AG | 671,925 | $11,154,000 | 0.28% |
| RA Capital Management | 363,051 | $6,027,000 | 0.26% |
| BDO Wealth Advisors, LLC | 35,234 | $585,000 | 0.17% |
| Birchview Capital, LP | 15,000 | $249,000 | 0.16% |
| SECOR Capital Advisors, LP | 37,205 | $618,000 | 0.13% |